redcrossA foundational barrier to informed consent among patients affiliated with Jehovah’s Witnesses is the long-standing, organizationally enforced belief that blood transfusions are inherently unsafe—often described as a form of “Russian Roulette.” These fears are deeply ingrained through decades of indoctrination, and empirical evidence suggests that such phobias often persist among former members long after they have left the faith.

The Misrepresentation of Statistical Risk

The diagram is from an article written by attorney Kerry Louderback Wood in the Journal Church and State.1 It shows what the risk of transfusion of Hepatitis B, C and HIV has been over the past four decades:

Figure 1 – Blood Transfusion Risks

Watchtower literature frequently presents outdated or cherry-picked statistics to characterise the risks of blood transfusion as prohibitively high. For example, official Watchtower publications continue to cite a risk rate of one death per 13,000 units of blood.2 The data they cite, and continue to publish as current for members, is more than 67 years old. Figure 2 is a screen capture from the JW.org website taken on June 5, 2026. In contrast, modern clinical data demonstrates that the actual risk of blood transfusion is very low. 3 4

This statistical disparity is stark: in the modern medical environment, a patient statistically faces a greater risk of mortality from a lightning strike than from a standardized blood transfusion.

Clinical Considerations for Risk-Benefit Analysis

When evaluating the necessity of blood products, clinicians and patients should consider the following parameters:

  • Risk-Benefit Ratio: Risks must be assessed in context. Blood products are typically prescribed to critically ill patients; the clinical decision must weigh the potential risk of the product against the significant risk of not receiving necessary treatment.
  • Competency of Counsel: Neither the Watchtower Society, local congregation elders, nor Hospital Liaison Committee (HLC) members possess the clinical credentials required to evaluate the risk-benefit ratio for an individual’s specific medical condition. These decisions should be made in consultation with licensed medical professionals, free from organisational pressure.
  • The Paradox of Approved Fractions: It is a significant clinical irony that the Watchtower Society approves the use of many blood-derived fractions. Because these fractions are often derived from the pooled plasma of hundreds or thousands of donors, they may carry a higher inherent risk of pathogen exposure than standard allogeneic red blood cell units.

Considerations for Jehovah’s Witness Patients Evaluating the Use of a Blood Product

1. Risks must be weighed against benefits. Many of these blood products are prescribed to very sick individuals. JW patients should consider not only the risk of using the blood product (whether or not it’s presently approved by the Watchtower Society) but also the risk of not taking it. Additionally, they should consider the history of the Watchtower’s blood policy as it has undergone many changes over the last eight decades, and more changes seem possible. The use of vaccines, organ transplants, blood fractions, and preoperative autologous whole blood donation was once all seen as serious sins, but are now permitted as a matter of conscience. Many Jehovah’s Witnesses died supporting these abandoned policies.

2. Many of the most problematic blood products are the ones approved for use by the Watchtower Society. This is because they are made from pooled blood from hundreds or thousands of individuals, thereby increasing the risk of exposure. This doesn’t mean that risk exceeds benefit. The irony is that Jehovah’s Witnesses have had a “green light” from the Watchtower Society to use the most risky blood products available (Hemophiliac preparations) since the 1970’s.

3. Neither the Watchtower Society, the elders in their congregation, nor even the Hospital Liaison Committee elders are qualified to help them evaluate the risk-benefit ratio for their particular medical condition. Privately explain the situation to them. Suggest they do their own research and make their own fully informed choice. If they are adults, respect their autonomous choice. Make use of available ethics and chaplaincy options.

Conclusion

The lack of transparency regarding transfusion safety within Watchtower literature is a critical concern, particularly when life-altering medical decisions are being made for minors or incapacitated patients. Clinicians are encouraged to provide clear, current, and objective risk data to patients and families to counteract the influence of organizationally implanted phobias.

References:

The Centers for Disease Control

The American Red Cross

The American Cancer Society

1. Journal of Church and State, Volume 47, Issue 4, Autumn 2005, Pages 707–723, https://doi.org/10.1093/jcs/47.4.707

2. https://www.jw.org/en/library/brochures/How-Can-Blood-Save-Your-Life/

3. Eleftherios C. VamvakasMorris A. Blajchman; Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 2009; 113 (15): 3406–3417. doi: https://doi.org/10.1182/blood-2008-10-167643

4. https://www.lifeblood.com.au/patients-recipients/blood-plasma-platelets/receiving-a-transfusion/informed-consent/transfusion-risks

A Note on Qualitative Patient Narratives:

The epidemiological data and statistical extrapolations presented in the text above are intended for clinical and bioethical review. However, AJWRB recognizes that behind every demographic statistic is a profound personal impact. The comment forum below is maintained as an open space for current members, former members, and their families to share their lived experiences regarding the blood prohibition. Please note that while these community-generated narratives are anecdotal and remain strictly distinct from our clinical data, we preserve them as vital qualitative perspectives on the real-world consequences of institutional medical directives.